Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
One World ProductsOWPC +66.67% EV-to-EBITDA is 0.98 as of Jul. 29, 2026. The stock has 4 warning signs investors should review. Among 744 Drug Manufacturers companies, One World Products ranks better than 96.1% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, One World Products's enterprise value is $4.88 Mil.
One World Products's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $4.97 Mil. Therefore, One World Products's EV-to-EBITDA for today is 0.98.
The historical rank and industry rank for One World Products's EV-to-EBITDA or its related term are showing as below:
OWPC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -5.31 Med: -2.09 Max: 0.98
Current: 0.98
During the past 11 years, the highest EV-to-EBITDA of One World Products was 0.98. The lowest was -5.31. And the median was -2.09.
OWPC's EV-to-EBITDA is ranked better than 96.1% of 744
companies
in the Drug Manufacturers industry
Industry Median: 12.98
vs OWPC: 0.98
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
One World Products (OTCPK:OWPC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
One World Products's PE Ratio (TTM) for today is calculated as:
One World Products's share price for today is $0.001.
One World Products's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.032.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for One World Products's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OWPC vs CBSTQ, PTPI, KOAN: EV-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, One World Products's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
One World Products EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, One World Products's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where One World Products's EV-to-EBITDA falls into.
One World Products's current Enterprise Value is $4.88 Mil.
One World Products's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.97 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
One World Products (OWPC) has a EV-to-EBITDA of 0.98 as of Jul. 29, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on One World Products. According to the industry distribution chart, One World Products ranks #29 out of 744 companies in the Drug Manufacturers industry, placing it in the top 3.9%.
Is One World Products' EV-to-EBITDA too high?
One World Products' current EV-to-EBITDA is 0.98. The Drug Manufacturers industry median EV-to-EBITDA is 12.98. One World Products' value of 0.98 is 92.4% below this industry median. Based on the distribution chart, One World Products ranks #29 out of 744 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does One World Products' EV-to-EBITDA compare to CBSTQ and PTPI?
According to the Drug Manufacturers industry distribution chart, One World Products ranks #29 out of 744 companies for EV-to-EBITDA. This places One World Products in the top 4% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 12.98. One World Products' value of 0.98 is 92.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.98, based on 744 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. One World Products's current EV-to-EBITDA of 0.98 is 92.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on One World Products. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. One World Products's current EV-to-EBITDA is 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is One World Products stock overvalued right now?
One World Products (OWPC) has a current EV-to-EBITDA of 0.98. The current EV-to-EBITDA is 0.98 and 92.4% below the Drug Manufacturers industry median of 12.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For One World Products (OWPC), the current EV-to-EBITDA is 0.98 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
One World Products Inc along with its subsidiaries is engaged in the cultivation, production, and distribution of raw cannabis and hemp plant ingredients for both medical and industrial uses. It focuses on cultivating, processing, and supplying cannabis oil, distillate, and isolate to customer's specifications. The Company operates as a single segment, consisting of its CBD sales operations in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OWPC has been successfully added to your 
